Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guanghui Tian

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
European Journal of Medicinal Chemistry|October 9, 2025
Design, synthesis, and biological profiling of novel aryl-spirocyclic diamine derivatives with potential antidepressant-like propertiesJiefang Zheng, Yaxin Tian, Jiaxin Cheng, et al.
European Journal of Medicinal Chemistry|February 14, 2025
D-morphinan analogs with favorable pharmacokinetic profiles as dual-acting antidepressantsJing Ji, Zhengtao Hu, Fuqiang Zheng, et al.
Journal of Medicinal Chemistry|November 10, 2012
Design, synthesis, and pharmacological evaluation of monocyclic pyrimidinones as novel inhibitors of PDE5Guan Wang, Zheng Liu, Tiantian Chen, et al.
Journal of Medicinal Chemistry|April 28, 2025
Design and Development of a Novel Oral 4'-Fluorouridine Double Prodrug VV261 against SFTSVYong Cheng, Wei Zheng, Xinru Dong, et al.
European Journal of Medicinal Chemistry|April 6, 2025
Heterocycle-fused phenylcyclohexylamines as novel multi-target antagonists of N-methyl-D-aspartate (NMDA) receptor and monoamine transporter for treating depressionFuqiang Zheng, Zhengtao Hu, Hai Chen, et al.
Journal of Medicinal Chemistry|April 26, 2019
Pharmacokinetics-Driven Optimization of 4(3 H)-Pyrimidinones as Phosphodiesterase Type 5 Inhibitors Leading to TPN171, a Clinical Candidate for the Treatment of Pulmonary Arterial HypertensionZhen Wang, Xiangrui Jiang, Xianglei Zhang, et al.
Science (New York, N.Y.)|May 3, 2020
Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivirWanchao Yin, Chunyou Mao, Xiaodong Luan, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
European Journal of Medicinal Chemistry|October 9, 2025
Design, synthesis, and biological profiling of novel aryl-spirocyclic diamine derivatives with potential antidepressant-like propertiesJiefang Zheng, Yaxin Tian, Jiaxin Cheng, et al.
European Journal of Medicinal Chemistry|February 14, 2025
D-morphinan analogs with favorable pharmacokinetic profiles as dual-acting antidepressantsJing Ji, Zhengtao Hu, Fuqiang Zheng, et al.
Journal of Medicinal Chemistry|November 10, 2012
Design, synthesis, and pharmacological evaluation of monocyclic pyrimidinones as novel inhibitors of PDE5Guan Wang, Zheng Liu, Tiantian Chen, et al.
Journal of Medicinal Chemistry|April 28, 2025
Design and Development of a Novel Oral 4'-Fluorouridine Double Prodrug VV261 against SFTSVYong Cheng, Wei Zheng, Xinru Dong, et al.
European Journal of Medicinal Chemistry|April 6, 2025
Heterocycle-fused phenylcyclohexylamines as novel multi-target antagonists of N-methyl-D-aspartate (NMDA) receptor and monoamine transporter for treating depressionFuqiang Zheng, Zhengtao Hu, Hai Chen, et al.
Journal of Medicinal Chemistry|April 26, 2019
Pharmacokinetics-Driven Optimization of 4(3 H)-Pyrimidinones as Phosphodiesterase Type 5 Inhibitors Leading to TPN171, a Clinical Candidate for the Treatment of Pulmonary Arterial HypertensionZhen Wang, Xiangrui Jiang, Xianglei Zhang, et al.
Science (New York, N.Y.)|May 3, 2020
Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivirWanchao Yin, Chunyou Mao, Xiaodong Luan, et al.
Pageof 6